Lataa...
Development of a novel 3-month drug releasing risperidone microspheres
OBJECTIVE: The purpose of this study was to develop an ideal microsphere formulation of risperidone that would prolong the drug release for 3 months in vivo and avoid the need for co-administration of oral tablets. MATERIALS AND METHODS: Polycaprolactones (PCL) were used as polymers to prepare micro...
Tallennettuna:
| Julkaisussa: | J Pharm Bioallied Sci |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333626/ https://ncbi.nlm.nih.gov/pubmed/25709335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0975-7406.148777 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|